Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00511030 · ClinicalTrials.gov registry record
Assessment of Stability of Mail-in Capillary Hemoglobin A1c Test Kit
A clinical trial of Diabetes, sponsored by Children's Mercy Hospital Kansas City.
- Completed
- Registry status
- 23
- Enrollment target
- 1
- Study location
NCT00511030 is a study of Diabetes that has completed, run by Children's Mercy Hospital Kansas City. The registered enrollment target is 23 participants, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00511030, a study of Diabetes, has completed, sponsored by Children's Mercy Hospital Kansas City.
- COMPLETED
- Registry status
- 23 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine the stability of capillary HBA1c blood samples collected by the participant with this kit and mailed to the laboratory at Children's Mercy Hospital.
Conditions Studied
Study Locations (1)
Missouri
- Children's Mercy Hospital - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2007-07 |
| Est. Completion | 2008-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00511030
The ClinicalTrials.gov registry entry for NCT00511030 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (99% lower). The listed sponsor is Children's Mercy Hospital Kansas City, which has 184 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Diabetes appearing as the primary indexed condition, and to 0 interventions.
NCT00511030 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT00511030 about?
NCT00511030 is a clinical study titled "Assessment of Stability of Mail-in Capillary Hemoglobin A1c Test Kit". The purpose of this study is to determine the stability of capillary HBA1c blood samples collected by the participant with this kit and mailed to the laboratory at Children's Mercy Hospital.
What is the current status of trial NCT00511030?
This trial is currently completed. The enrollment target is 23 participants. The study started on 2007-07. Estimated completion is 2008-01.
What conditions does trial NCT00511030 study?
This clinical trial studies the following conditions: Diabetes.
Who is sponsoring clinical trial NCT00511030?
This trial is sponsored by Children's Mercy Hospital Kansas City, which has 184 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00511030 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
DFC 004 Biomarkers for Active Diabetic Foot Ulcers
RECRUITING
-
Effect of 2-Week Continuous Glucose Monitoring on Glycemic Management in Patients New-to-Insulin on Hospital Discharge
RECRUITING · NA
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children
RECRUITING · NA
-
Taste Bud-Derived Stem Cells in Humans
RECRUITING
-
Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.